Role of Digital Breast Tomosynthesis in Screening and Diagnostic Breast Imaging

Digital breast tomosynthesis is quickly becoming the standard of care in breast cancer screening and diagnosis. Since its introduction to the clinical landscape in 2011, radiologists specializing in breast disease diagnosis around the country have made the decision to adopt the technology for both screening and diagnostic applications; with adoption growing substantially in present day. Users of the technology have attested to the benefits the technology affords, both in screening and the diagnostic evaluation of patients, through peer-reviewed publications and scientific presentations in recent years. This review article will describe the history of digital breast tomosynthesis and its implementation; from the early days of research, through Food and Drug Administration approval, to integration into the clinical workflow, in the setting of screening and diagnostic evaluation.